Valneva Scotland Ltd, the largest vaccine producer in Scotland, has been awarded the esteemed Silver Award for health and safety excellence by the Royal Society for the Prevention of Accidents (RoSPA). This recognition highlights Valneva’s commitment to maintaining the highest standards of safety and excellence within the workplace. The award ceremony, held in London, celebrated the company’s outstanding health and safety performance, policies, and procedures, reflecting their dedication to creating a safe working environment for their employees.
Commitment to Safety Excellence
Valneva Scotland’s achievement of the Silver Award is a testament to their unwavering commitment to health and safety. The company has implemented robust management systems that consistently drive improvement and ensure the well-being of their employees. This accolade not only recognizes their current efforts but also sets a benchmark for future safety initiatives. The rigorous application process for the RoSPA award, which took nearly three months to complete, underscores the thoroughness and dedication of Valneva’s health and safety team.
The recognition from RoSPA is not the first for Valneva Scotland. The company has previously been acknowledged in the 2024 Life Sciences Scotland Awards, winning in two categories: Innovation – Pharma Services & Drug Discovery and Outstanding Skills Development Award. These accolades further emphasize Valneva’s role as a leader in the life sciences sector, continually striving for excellence in all aspects of their operations.
Greig Rooney, Managing Director at Valneva Scotland Ltd, expressed his pride in the company’s achievements, stating, “Valneva is contributing to a world in which no one suffers from vaccine-preventable diseases. This health and safety recognition reflects our commitment to be the best life science organization to work for, putting our 180 highly skilled team members at the center of everything we do.”
A Culture of Safety
At Valneva Scotland, safety is more than just a priority; it is ingrained in the company’s culture. The health and safety team, led by OHSE Manager Kathleen Haddow, works tirelessly to maintain rigorous standards and foster ongoing development for all team members. The Silver Award from RoSPA is a reflection of these efforts, bringing international recognition to Valneva’s safety performance.
The company’s dedication to safety extends beyond compliance with regulations. Valneva actively promotes a culture of continuous improvement, encouraging employees to participate in safety initiatives and providing regular training to enhance their skills. This proactive approach ensures that safety remains at the forefront of all operations, protecting both employees and the wider community.
Paulina Meducka, a member of the health and safety team, highlighted the significance of the award, saying, “This momentous award from RoSPA brings international recognition for our safety performance. Safety is an ongoing priority and baked into our culture at Valneva Scotland.”
Future Aspirations
Looking ahead, Valneva Scotland aims to build on their success and continue to lead the way in health and safety excellence. The company plans to further enhance their safety protocols and invest in new technologies to support their safety initiatives. By maintaining a strong focus on health and safety, Valneva hopes to inspire other organizations within the life sciences sector to prioritize the well-being of their employees.
The Silver Award from RoSPA serves as a reminder of the importance of health and safety in the workplace. Valneva Scotland’s achievement sets a high standard for others to follow, demonstrating that excellence in safety is achievable through dedication, innovation, and a commitment to continuous improvement.
As Valneva Scotland continues to grow and expand their operations, their focus on health and safety will remain a cornerstone of their success. The company’s ongoing efforts to create a safe and supportive working environment will undoubtedly contribute to their future achievements and reinforce their reputation as a leader in the life sciences industry.
